BIOLASE to Present at Canaccord Genuity 2012 Medical Technology

BIOLASE to Present at Canaccord Genuity 2012 Medical Technology &
Diagnostics Forum 
IRVINE, CA -- (Marketwire) -- 11/26/12 --  BIOLASE, Inc. (NASDAQ:
BIOL), the world's leading dental laser manufacturer and distributor,
announced today that Fred Furry, Chief Operating Officer and Chief
Financial Officer, is scheduled to present at the Canaccord Genuity
2012 Medical Technology & Diagnostics Forum as follows: 
Date: Tuesday, December 4
 Time: 4:00 pm Eastern Standard Time 
Location: Le Parker Meridien, New York, NY
 Live audio webcast: under "Investors" or 
Following its completion, a replay of the presentation will be
available through December 18, 2012, on BIOLASE's website at under the "Investors" section. 
About BIOLASE, Inc.
 BIOLASE, Inc. is a biomedical company that
develops, manufactures and markets dental lasers and also distributes
and markets dental imaging equipment; products that are focused on
technologies that advance the practice of dentistry and medicine. The
Company's laser products incorporate approximately 290 patented and
patent-pending technologies designed to provide biologically
clinically superior performance with less pain and faster recovery
times. Its imaging products provide cutting-edge technology at
competitive prices to deliver the best results for dentists and
patients. BIOLASE's principal products are dental laser systems that
perform a broad range of dental procedures, including cosmetic and
complex surgical applications, and a full line of dental imaging
equipment. BIOLASE has sold more than 20,600 lasers. Other products
under development address ophthalmology and other medical and
consumer markets. 
For updates and information on WaterLase and laser dentistry, find
BIOLASE online at, Facebook at, Twitter at, and
YouTube at  
For further information, please contact: 
Lisa Wilson 
In-Site Communications, Inc. 
Press spacebar to pause and continue. Press esc to stop.